Sex Disparities in <i>MGMT</i> Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts

Sex Disparities in <i>MGMT</i> Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts

Introduction: Recent studies suggest an overrepresentation of <i>MGMT</i> promoter methylated tumors in females with <i>IDH</i>wt glioblastoma (GBM) compared to males, with a subsequent better response to alkylating treatment. Methods: To reveal sex-bound associations that ma...

Full description

Bibliographic Details
Main Authors:	Anja Smits, Malgorzata Lysiak, Andreas Magnusson, Johan Rosell, Peter Söderkvist, Annika Malmström
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Journal of Clinical Medicine
Subjects:	glioblastoma <i>MGMT</i> promoter methylation survival sex disparities
Online Access:	https://www.mdpi.com/2077-0383/10/4/556

Similar Items

Development of A Radiomic Model for <i>MGMT</i> Promoter Methylation Detection in Glioblastoma Using Conventional MRI
by: Fabio M. Doniselli, et al.
Published: (2023-12-01)

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma
by: Miyuki Uno, et al.
Published: (2011-01-01)

Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran
by: Kazem Anvari, et al.
Published: (2018-07-01)

Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide
by: Konstantin R. Brawanski, et al.
Published: (2023-03-01)

Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells
by: Remi Weber, et al.
Published: (2024-01-01)

Association of <i>MGMT</i> Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma
by: Katja Zappe, et al.
Published: (2023-12-01)

Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01)

Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01)

<i>MGMT</i> Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
by: Mateusz Szylberg, et al.
Published: (2022-08-01)

Association between <i>MGMT</i> Enhancer Methylation and <i>MGMT</i> Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
by: Katja Zappe, et al.
Published: (2023-06-01)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
by: Fatih Incekara, et al.
Published: (2020-05-01)

Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated <i>MGMT</i>
by: María del Mar Álvarez-Torres, et al.
Published: (2021-10-01)

Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study
by: Mario Caccese, et al.
Published: (2022-05-01)

Lomeguatrib Increases the Radiosensitivity of MGMT Unmethylated Human Glioblastoma Multiforme Cell Lines
by: Anna Kirstein, et al.
Published: (2021-06-01)

MRI-Based Deep Learning Tools for MGMT Promoter Methylation Detection: A Thorough Evaluation
by: Lucas Robinet, et al.
Published: (2023-04-01)

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
by: Magda Sayed Mahmoud, et al.
Published: (2024-03-01)

Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma
by: Valentin Karl Ladenhauf, et al.
Published: (2023-02-01)

The Impact of <i>MGMT</i> Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma
by: Nikola Jovanović, et al.
Published: (2019-02-01)

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
by: David Gibson, et al.
Published: (2024-03-01)

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
by: Anna Kirstein, et al.
Published: (2020-04-01)

The Significance of <i>MGMT</i> Promoter Methylation Status in Diffuse Glioma
by: Nikola Jovanović, et al.
Published: (2022-10-01)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
by: Melguizo Consolación, et al.
Published: (2012-12-01)

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
by: Federico Cucchiara, et al.
Published: (2022-07-01)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
by: Giovanni Brigliadori, et al.
Published: (2020-10-01)

A Multimodal Knowledge-Based Deep Learning Approach for MGMT Promoter Methylation Identification
by: Salvatore Capuozzo, et al.
Published: (2022-12-01)

Transcriptional Pausing and Activation at Exons-1 and -2, Respectively, Mediate the <i>MGMT</i> Gene Expression in Human Glioblastoma Cells
by: Mohammed A. Ibrahim Al-Obaide, et al.
Published: (2021-06-01)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
by: Sudhir Raghavan, et al.
Published: (2020-02-01)

Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma
by: Xinyu Han, et al.
Published: (2023-10-01)

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
by: Rui-Chao Chai, et al.
Published: (2019-09-01)

Computational pathology-based weakly supervised prediction model for MGMT promoter methylation status in glioblastoma
by: Yongqi He, et al.
Published: (2024-02-01)

MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value
by: Henning Leske, et al.
Published: (2023-08-01)

The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
by: Fatih Incekara, et al.
Published: (2020-07-01)

Less Severe Polymicrobial Sepsis in Conditional <i>mgmt</i>-Deleted Mice Using LysM-Cre System, Impacts of DNA Methylation and MGMT Inhibitor in Sepsis
by: Kritsanawan Sae-khow, et al.
Published: (2023-06-01)

Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
by: Nelli S. Lakis, et al.
Published: (2022-11-01)

MGMT Promoter Methylation: Prognostication beyond Treatment Response
by: Keyoumars Ashkan, et al.
Published: (2023-06-01)

MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma
by: Erdal Tasci, et al.
Published: (2024-04-01)

Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
by: Sophie Richard, et al.
Published: (2020-09-01)

Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial
by: Andrea Pace, et al.
Published: (2023-12-01)

MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme
by: Rosa Della Monica, et al.
Published: (2022-06-01)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
by: Francesco Marchi, et al.
Published: (2020-01-01)